FingerprintDive into the research topics of 'Pegvaliase dose escalation to 80 mg daily may lead to efficacy in patients who do not exhibit an optimal response at lower doses'. Together they form a unique fingerprint.
- Sort by
Erika R. Vucko*, Kirsten E. Havens, Joshua J. Baker, Barbara K. Burton
Research output: Contribution to journal › Article › peer-review